Fort Worth, TXOn January 10, 2025, the Northern District of Texas rendered a decision in Spence v. American Airlines, Inc. The ruling (much to the surprise of many) does not challenge the... Read more »
AbbVie, AstraZeneca, and GSK are among the 10 companies now under scrutiny by the Federal Trade Commission, which is cracking down on businesses it says improperly or inaccurately placed items on a... Read more »
From left to right: Kate Huey, partner, business transformation leader for health care, Ernst & Young; Jeffrey Ries, executive director, JPMorgan Chase & Co.; Chris Turner, CEO, HealthBook+; Bipinchandra (Bipin) Mistry, MD,... Read more »
Local prosecutors hold enormous power over the outcomes of criminal cases. Their decisions – whether to file a case, what charges to bring, what dispositions to offer, and what sentences to seek... Read more »
From left to right: Hubert Zajicek, MD, CEO, co-founder & partner, Health Wildcatters; Kristen Torres Mowat, partner, Health Velocity Capital; Harsh Vathsangam, CEO, Movn Health; Kerry Rupp, general partner, True Wealth Ventures;... Read more »
It’s not an easy time to be a retail pharmacy chain. This is especially true for Rite Aid, which filed for Chapter 11 bankruptcy protection in New Jersey on Sunday. In order... Read more »
More than half of Medicare beneficiaries are enrolled in Medicare Advantage (MA), and enrollment in MA has steadily grown over the years. But as the MA program draws scrutiny from the federal... Read more »
After Cigna agreed to pay $172 million to resolve allegations that it violated the False Claims Act in its Medicare Advantage plans, it begs this question: Is the insurer deserving of this... Read more »
